These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31556133)

  • 1. Novel insights into the complex architecture of osteoporosis molecular genetics.
    Saad FA
    Ann N Y Acad Sci; 2020 Feb; 1462(1):37-52. PubMed ID: 31556133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuna Bone Powder Alleviates Glucocorticoid-Induced Osteoporosis via Coregulation of the NF-κB and Wnt/β-Catenin Signaling Pathways and Modulation of Gut Microbiota Composition and Metabolism.
    Li J; Yang M; Lu C; Han J; Tang S; Zhou J; Li Y; Ming T; Wang ZJ; Su X
    Mol Nutr Food Res; 2020 Mar; 64(5):e1900861. PubMed ID: 31953894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G; Xu Q; Dai M; Liu X
    Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional Chinese medicine Bushen-Jianpi-Huoxue decoction prevents diabetic osteoporosis in rats via Wnt and nuclear factor-kappa B signaling pathways.
    Zhang Y; Liu M; Li H; Chen Z; Liang N; Xu J; Zhang X; Zhang Y
    Int J Rheum Dis; 2017 Aug; 20(8):941-948. PubMed ID: 28294540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders.
    Marini F; Giusti F; Palmini G; Brandi ML
    Osteoporos Int; 2023 Feb; 34(2):213-238. PubMed ID: 35982318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of glucocorticoid-induced osteoporosis.
    van Brussel MS; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2009 Apr; 10(6):997-1005. PubMed ID: 19351276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.
    Sato AY; Cregor M; Delgado-Calle J; Condon KW; Allen MR; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2016 Oct; 31(10):1791-1802. PubMed ID: 27163932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Romosozumab for the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Biol Ther; 2017 Feb; 17(2):255-263. PubMed ID: 28064540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
    Bhattacharyya S; Pal S; Chattopadhyay N
    Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting WNT signaling in the treatment of osteoporosis.
    Baron R; Gori F
    Curr Opin Pharmacol; 2018 Jun; 40():134-141. PubMed ID: 29753194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Approaches To Identifying Novel Osteoporosis Drug Targets.
    Brommage R
    J Cell Biochem; 2015 Oct; 116(10):2139-45. PubMed ID: 25833316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bone remodelling cycle.
    Kenkre JS; Bassett J
    Ann Clin Biochem; 2018 May; 55(3):308-327. PubMed ID: 29368538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irisin as an agent for protecting against osteoporosis: A review of the current mechanisms and pathways.
    Hu X; Wang Z; Wang W; Cui P; Kong C; Chen X; Lu S
    J Adv Res; 2024 Aug; 62():175-186. PubMed ID: 37669714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of bone metabolism in osteoporosis : novel drugs for osteoporosis in development].
    Jakob F; Genest F; Baron G; Stumpf U; Rudert M; Seefried L
    Unfallchirurg; 2015 Nov; 118(11):925-32. PubMed ID: 26471379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].
    Kitao T; Ito Y; Fukui M; Yamamoto M; Shoji Y; Takeda S; Shirahase H
    Yakugaku Zasshi; 2019; 139(1):19-25. PubMed ID: 30606923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/β-catenin signalling pathway.
    Du L; Nong MN; Zhao JM; Peng XM; Zong SH; Zeng GF
    Sci Rep; 2016 Aug; 6():32261. PubMed ID: 27554324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Melatonin and bone status].
    Ostrowska Z; Wołkowska-Pokrywa K; Kos-Kudła B; Swietochowska E; Marek B; Kajdaniuk D
    Pol Merkur Lekarski; 2006 Oct; 21(124):389-93. PubMed ID: 17205785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].
    Neumann E
    Z Rheumatol; 2006 Sep; 65(5):400, 402-6. PubMed ID: 16924451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.